Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha

Autoimmunity ◽  
2007 ◽  
Vol 40 (4) ◽  
pp. 331-332 ◽  
Author(s):  
P. Heyder ◽  
I. Bekeredjian-Ding ◽  
M. Parcina ◽  
N. Blank ◽  
A. D. Ho ◽  
...  
2009 ◽  
Vol 46 (14) ◽  
pp. 2857
Author(s):  
Christian Lood ◽  
Birgitta Gullstrand ◽  
Lennart Truedsson ◽  
Anders I. Olin ◽  
Gunnar V. Alm ◽  
...  

2007 ◽  
Vol 85 (5) ◽  
pp. 383-390 ◽  
Author(s):  
Evelin Grage‐Griebenow ◽  
Stefan Löseke ◽  
Marion Kauth ◽  
Kirsten Gehlhar ◽  
Rainer Zawatzky ◽  
...  

2007 ◽  
Vol 30 (4) ◽  
pp. 84
Author(s):  
Martin D. Hyrcza ◽  
Sandy S. Der ◽  
Mario Ostrowski

Background: Plasmacytoid dendritic cells (pDCs) are the most potent producers of type I interferons (IFN). Human genome contains thirteen IFN alpha genes and one IFN beta gene. Research in mice suggests that different IFNs are induced by different stimuli, but whether this is true in human cells is unknown. Patients with HIV-1 infection show chronic interferon response in peripheral T cells, which caused us to analyze the induction of the IFN alpha genes in their dendritic cells. Methods: Uninfected, acutely infected and long-term non-progressive donors were leukopheresed, following which pDCs were isolated by negative depletion. The dendritic cells were then treated for with one of the following: influenza virus, sendai virus, HIV virus, CpG DNA, imiquimod, or media alone, and the cells’ RNA was analysed by real time qPCR for changes in the RNA levels of four IFN alpha genes: α1, α2, α7, α8, as well as IFN beta. Results: Final results were not available at the time of abstract deposition.


2017 ◽  
Vol 2017 ◽  
pp. 1-12 ◽  
Author(s):  
L. Kui ◽  
G. C. Chan ◽  
P. P. W. Lee

Proinflammatory cytokines such as TNF-α and type I interferons (IFN) are pathogenic signatures of systemic lupus erythematosus, and plasmacytoid dendritic cells (pDCs) play a major role by predominantly producing IFN-α. Given the rise of importance in identifying tumor necrosis stimulated gene 6 (TSG-6) as a key anti-inflammatory regulator, we investigate its function and its ability to counteract proinflammatory cytokine secretion by pDCs in vitro. CpG-A and R837 induced significant endogenous TSG-6 expression in the pDC cell-line GEN2.2. Following recombinant human TSG-6 treatment and CpG-A or R837 stimulation, significant reduction in IFN-α and TNF-α was observed in healthy donors’ pDCs, and the same phenomenon was confirmed in GEN2.2. By CD44 blocking assay, we deduced that the suppressive effect of TSG-6 is mediated by CD44, by reducing IRF-7 phosphorylation. Our findings suggest that TSG-6 and its downstream signalling pathway could potentially be targeted to modulate proinflammatory cytokine expression in pDCs.


2012 ◽  
Vol 91 (5) ◽  
pp. 751-758 ◽  
Author(s):  
Patricia Bastos-Amador ◽  
Begoña Pérez-Cabezas ◽  
Nuria Izquierdo-Useros ◽  
Maria C. Puertas ◽  
Javier Martinez-Picado ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document